Development of the chimeric protein PTENCiV, which fully reproduced the substrate specificity of wild-type PTEN and could be activated by membrane depolarization, provided a novel approach for controlling the activity of PTEN and studying this important tumor suppressor (Lacroix et al., 2011). Here, PTEN is linked to neoplasm.